Medical device licence · 115215 · Class 3
COBAS LIAT SYSTEM
Yes: licensed in Canada
Licence status Issued (active); first licensed April 15, 2026. It is in Health Canada’s list of active licences.
- Licence number
- 115215
- Licence holder
- Roche Molecular Systems, IncBranchburg, NJ, United States
- Risk class
- Class III (moderate to high risk)
- Licence type
- System
- First licensed
- April 15, 2026
- Devices covered
- 8
Devices on this licence
By name, as listed. The official record lists model numbers and identifiers.
- COBAS LIAT ANALYZER
- COBAS LIAT SARS-COV-2 & INFLUENZA A/B V2
- COBAS LIAT SARS-COV-2 V2
- COBAS LIAT SARS-COV-2, INFLUENZA A/B & RSV
- COBAS LIAT SARS-COV-2, INFLUENZA A/B & RSV CONTROL KIT
- SW COBAS LIAT SARS-COV-2 V2 V1.1.0
- SW COBAS LIAT SARS-COV-2, INFLUENZA A/B & RSV V1.1.0
- SW COBAS LIAT SARS-COV-2/& INFLUENZA A/B V2 V1.1.0
Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.